Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT StudyElizabeth Bancroft, Apollonia T. Helderman-van den Enden, Elizabeth Page et al.|European Urology|2014Cited by 250
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation CarriersElizabeth Page, Manuel R. Teixeira, D. Gareth Evans et al.|European Urology|2019Cited by 239
Targeted prostate cancer screening in men with mutations in <i>BRCA1</i> and <i>BRCA2</i> detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita Mitra, Alison Falconer, Elizabeth Bancroft et al.|British Journal of Urology|2010Cited by 98
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective studyElizabeth Bancroft, Alan Donaldson, Elizabeth Page et al.|The Lancet Oncology|2021Cited by 93
Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controlsSibel Saya, Rosalind A. Eeles, Emma Killick et al.|Familial Cancer|2017Cited by 68